File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: The role of 18F-Fluorodeoxyglucose positron emission tomography in thyroid neoplasms

TitleThe role of 18F-Fluorodeoxyglucose positron emission tomography in thyroid neoplasms
Authors
KeywordsFluorodeoxyglucose
Indeterminate cytology
Positron emission tomography
Thyroid carcinoma
Thyroid incidentaloma
Issue Date2011
PublisherAlphaMed Press, Inc. The Journal's web site is located at http://www.theoncologist.org/
Citation
The Oncologist, 2011, v. 16 n. 4, p. 458-466 How to Cite?
Abstract18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) has established itself as an important imaging modality in many oncological and nononcological specialties and, as a consequence, it is increasingly being used in clinical practice. Since the first report of FDG being taken up by metastatic differentiated thyroid carcinoma (DTC) cells >20 years ago, various groups of investigators have explored the potential role of FDG-PET scanning in patients with benign and malignant thyroid neoplasms. With the increasing demand for FDG-PET scanning, clinicians are faced with the challenge of managing an increasing number of FDGPET- detected thyroid incidentalomas because their significance remains unclear. The aims of this review are to address some of these issues, specifically, the clinical significance of FDG-PET-detected thyroid incidentalomas, the ability of FDG-PET to characterize thyroid nodules, especially those with indeterminate fine needle aspiration cytology results, and the role of FDG-PET in patients with confirmed primary DTC and with suspected recurrent DTC, by reviewing the current literature.
Persistent Identifierhttp://hdl.handle.net/10722/192058
ISSN
2015 Impact Factor: 4.789
2015 SCImago Journal Rankings: 2.391
PubMed Central ID
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorLang, BHH-
dc.contributor.authorLaw, TT-
dc.date.accessioned2013-10-16T08:45:28Z-
dc.date.available2013-10-16T08:45:28Z-
dc.date.issued2011-
dc.identifier.citationThe Oncologist, 2011, v. 16 n. 4, p. 458-466-
dc.identifier.issn1083-7159-
dc.identifier.urihttp://hdl.handle.net/10722/192058-
dc.description.abstract18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) has established itself as an important imaging modality in many oncological and nononcological specialties and, as a consequence, it is increasingly being used in clinical practice. Since the first report of FDG being taken up by metastatic differentiated thyroid carcinoma (DTC) cells >20 years ago, various groups of investigators have explored the potential role of FDG-PET scanning in patients with benign and malignant thyroid neoplasms. With the increasing demand for FDG-PET scanning, clinicians are faced with the challenge of managing an increasing number of FDGPET- detected thyroid incidentalomas because their significance remains unclear. The aims of this review are to address some of these issues, specifically, the clinical significance of FDG-PET-detected thyroid incidentalomas, the ability of FDG-PET to characterize thyroid nodules, especially those with indeterminate fine needle aspiration cytology results, and the role of FDG-PET in patients with confirmed primary DTC and with suspected recurrent DTC, by reviewing the current literature.-
dc.languageeng-
dc.publisherAlphaMed Press, Inc. The Journal's web site is located at http://www.theoncologist.org/-
dc.relation.ispartofThe Oncologist-
dc.subjectFluorodeoxyglucose-
dc.subjectIndeterminate cytology-
dc.subjectPositron emission tomography-
dc.subjectThyroid carcinoma-
dc.subjectThyroid incidentaloma-
dc.titleThe role of 18F-Fluorodeoxyglucose positron emission tomography in thyroid neoplasmsen_US
dc.typeArticleen_US
dc.identifier.emailLang, BHH: blang@hkucc.hku.hk-
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.1634/theoncologist.2010-0256-
dc.identifier.pmid21378078-
dc.identifier.pmcidPMC3228117-
dc.identifier.scopuseid_2-s2.0-79955012481-
dc.identifier.hkuros185527-
dc.identifier.volume16-
dc.identifier.issue4-
dc.identifier.spage458-
dc.identifier.epage466-
dc.identifier.isiWOS:000289558200008-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats